new glp-1 agonists England Journalist of Medicine published great article. Read it to learn more about the science behind medications. GLP-1 receptor are increasingly used to treat type 2 diabetes and obesity Switching between GLP‐1 receptor agonists

Initially developed for Type 2 Diabetes (T2D), GLP-1 drugs are now widely used in obesity/weight loss management, with emerging applications in cardiovascular and neurodegenerative diseases

All content is framed for research use only no clinical or therapeutic claims are made

If you have very little body fat, a 45 angle may be more comfortable

54 , 55 While the treatment of many other diseases are being explored, there is conflicting evidence regarding the impact of GLP-1 agonists on areas that directly impact physical therapist practice such as OA and bone density

Specific drug costs in the GLP-1 class can be quite shocking